Avalon Investment & Advisory’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-22,028	Closed	-$3.77M	–	328
2018 Q3	$3.77M	Buy	22,028 +1,558	+8%	+$267K	0.11%	175
2018 Q2	$2.65M	Buy	20,470 +1,848	+10%	+$239K	0.08%	203
2018 Q1	$1.92M	Buy	+18,622	New	+$1.92M	0.06%	218